| |
ALZHEIMER DISEASE RESEARCH CENTER: STATISTICS (ADRC)
1.1 Wilkosz P, Miyahara S, Lopez OL, DeKosky ST, Sweet RA. "Prediction of psychosis onset in Alzheimer Disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes." American Journal of Geriatric Psychiatry 2006;14:352-360.
1.2 Lopez OL, Miyahara S, Becker JT, Sweet RA, Klunk W, Saxton J, DeKosky ST. "Incident psychiatric symptoms predict conversion to dementia in mild cognitive impairment subgroups." J Vellas (Ed.). Research and Practice in Alzheimer's Disease 2005. In Press.
1.3 Perez-Madriņan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI, Aizenstein HJ, DeKosky ST, Sweet RA. "Psychosis in Alzheimer Disease: Excess cognitive impairment is restricted to the misidentification subtype." American Journal of Geriatric Psychiatry 2004;12(5): 449-456.
1.4 Saxton J, Becker JT, Wisniewski SR. "The Rey-Osterrieth Complex Figure and Dementia Handbook of Rey-Osterrieth Complex Figure Usage: Clinical and Research Applications." J.A. Knight & E.F. Kaplan (Eds.) Odessa, FL: Psychological Assessment Resources 2003.
1.5 DeKosky ST, Ikonomovic MD, Wang X, Farlow M, Wisniewski SR, Lopez OL, Becker JT, Saxton J, Klunk WE, Sweet R, Kaufer KI, Kamboh MI. "Plasma and cerebrospinal fluid 1-antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive? impairment." Annals of Neurology 2003;53:81-90.
1.6 Cook SE, Miyahara S, Bacanu SA, Perex G, Lopez OL, Kaufer KL, Nimgaonkar VL, Wisniewski SR, DeKosky ST, Sweet RA. "Psychotic Symptoms in Alzheimer's Disease: Evidence for Subtypes." American Journal of Geriatric Psychiatry 2003;11:406-413.
1.7 DeKosky ST, Ikonomivic MD, Styren SD, Beckett L, Wisniewski SR, Bennett D, Kordower JH, Mufson EJ. "Upregulation of Choline Acetyltransferase Activity in Hippocampus and Frontal Cortex of Elderly Subjects with Mild Cognitive Impairment." Annals of Neurology 2002;51:145-155.
1.8 Lopez OL, Becker JT, Wisniewski SR, Saxton J, Kaufer DI, DeKosky ST. "Cholisterase inhibitor treatment alters the natural history of Alzheimer's disease." Journal of Neurology Neurosurgery and Psychiatry 2002; 72:310-314.
1.9 Sweet RA, Kamboh MI, Wisniewski SR, Lopez OL, Klunk WE, Kaufer DI, DeKosky ST. "APOE and ACT genotypes do not predict time to psychosis in alzheimer's disease." Journal of Geriatric Psychiatry and Neurology 2002;15:24-30.
1.10 Whyte EM, Mulsant BH, Butters MA, Qayyum M, Towers A, Sweet RA, Klunk W, Wisniewski SR, DeKosky ST. "Cognitive and behavorial correlates of low B12 in elderly patients with progressive dementia." American Journal of Geriatric Psychiatry 2002;10:321-327.
1.11 Sweet RA, Hamilton RL, Healy Mt, Wisniewski SR, Henteleff R, Pollock BG, Lewis DA, DeKosky ST. "Alterations of striatal dopamine receptor binding in Alzheimer's disease are associated with lewy body pathology and with antemortem psychosis." Archives of Neurology 2001;58:466-472.
1.12 Sweet RA, Hamilton RL, Lopez OL, Klunk WE, Wisniewski SR, Kaufer DI, Healy MT, DeKosky ST. "Psychotic symptoms in alzheimer's disease are not associated with more severe neuropathologic features." International Psychogeriatrics 2001;12:547-558.
1.13 Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer MD, Sweet R, Meltzer CC, Wisniewski SR, Kamboh MI, DeKosky ST. "Research evaluation and diagnosis of dementia: I-probable Alzheimer's disease." Neurology 2000;55:1854-1860.
1.14 Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI. "Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist (IL-1RN) genes and the risk of Alzheimer's Disease." Letter in Annals of Neurology 2000;48:817-818.
1.15 Lopez OL, Wisniewski SR, Hamilton Rl, Becker JT, Kaufer DI, DeKosky ST. "Predictors of progression in patients with Alzheimer's disease and Lewy bodies." Neurology 2000;54:1774-1779.
1.16 Lopez OL, Hamilton RL, Becker JT, Wisniewski SR, Kaufer DI, DeKosky ST. "Severity of cognitive impairment and the clinical diagnosis of Alzheimer's disease with Lewy bodies." Neurology 2000;54:1780-1787.
1.17 Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST. "Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer's disease." Arch of Neurology 1999;56:1266-1272.
1.18 Wang X, DeKosky ST, Wisniewski SR, Aston CE, Kamboh MI. "Genetic association of two chromosome 14 genes (presenilin 1 and 1-antichymotrypsin) with Alzheimer's disease." Annals of Neurology 1998;44:387-390.
1.19 Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST. "Subtle extrapyramidal signs in patients with probable Alzheimer's disease." Arch of Neurology 1997;54:969-975.
1.20 Koslow SA, Swihart AA, Latehaw RE, Hirseh WL, Belle SH, Shim YK, Boller F. "Quantitative computer tomography in Alzheimer's disease: A re-evaluation." Gerontology 1992;38:174-184.
1.21 Huff FJ, Belle SH, Shim YK, Ganguli M, Boller F. "Prevalence and prognostic value of neurologic abnormalities in Alzheimer's disease." Dementia 1990;1:32-49.
1.22 Boller F, Huff FJ, Querriera R, Kelsey SF, Beyer J. "Recording neurological symptoms and signs in Alzheimer's disease." Am J Alzheimer's Dis Care and Research 1987.
1.23 Huff FJ, Beeker JT, Belle SH, Nebes RH, Holland AL, Boller F. "Cognitive deficits and clinical diagnosis of Alzheimer's disease." Neurology 1987;37:1119-1124.
1.24 Huff FJ, Boller F, Lueehelli F, Querriera R, Beyer J, Belle SH. "Neurological examination in patients with probable Alzheimer's disease." Arch Neurol 1987;44:929-932.
ARTIFICIAL VALVE ENDOCARDITIS REDUCTION TRIAL (AVERT)
2.1 Englberger L, Schaff HV, Jamieson WRE, Kennard ED, Im KA, Holubkov R, Carrel TP, For The Avert Investigators. "Importance of Implant Technique on Risk of Major Paravalvular Leak (PVL) After St Jude Mechanical Heart Valve Replacement: A Report From The Artificial Valve Endocarditis Reduction Trial (Avert)" European Journal Of Cardiothoracic Surgery 2005;28:838-843.
2.2 Schaff HV, Carrel TP, Jamieson WRE, Jones KW, Ruficlanchas JJ, Cooley DA, Hetzer R, Stumpe F, Duveau D, Moseley P, van Boven WJ, Grunkemeier GL, Kennard ED, Holubkov R. "Paravalvular leak and other events in Silzone-coated mechanical heart valves: A report from AVERT" Am Thorac Surg 2002;73(3):785-92.
2.3 Englberger L, Carrel T, Schaff HF, Kennard ED, Holubkov R. "Differences in heart valve procedures between North American and European centers: A report from the Artificial Valve Endocarditis Reduction Trial (AVERT). J Heart Valve Dis 2001;10(5):562-71.
2.4 Schaff HV, Carrel T, Steckelberg JM, Grunkemeier GL, Holubkov R. "Artificial Valve Endocarditis Reduction Trial (AVERT): Protocol of a multicenter randomized trial." Journal of Heart Valve Disease 1999;8:131-139.
BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES (BARI 2D)
3.1 Sobel BE, Frye R, Detre KM. "Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial." Circulation 2003;107: 636-642.
BIOBEHAVIORAL STUDlES OF CARDIOVASCULAR DISEASE: STATISTICS, RECRUITMENT, AND DATA MANAGEMENT CORE
4.1 Petersen KL, Bleil ME, McCaffery J, Mackey RH, Sutton-Tyrrell K, Muldoon MF, Manuck SB. "Community socioeconomic status is associated with carotid artery atherosclerosis in untreated, hypertensive men." Am J Hyp 2006. In Press.
4.2 Muldoon MF, Mackey RH, Williams KV, Korytkowski MT, Flory JD, Manuck SB. "Metabolic syndrome is associated with low central nervous system serotonergic responsivity." J Clin Endo Metab 2006. In Press.
4.3 Janicki DL, Kamarck TW, Shiffman S, Sutton-Tyrrell K, Gwaltney CJ. "Frequency of spousal interaction and 3-year progression of carotid artery intima medial thickness: the Pittsburgh Healthy Heart Project." Psychosom Med 2005;67:889-896.
4.4 Kamarck TW, Schwartz JE, Shiffman S, Muldoon MF, Sutton-Tyrrell K, Janicki DL. "Psychosocial stress and cardiovascular risk: what is the role of daily experience?" J Pers 2005;73:1749-1774.
4.5 Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, van der Veen FM, Meltzer CC. "Reduced cerebral blood flow response and compensation among patients with untreated hypertension." Neurology 2005;64:1358-1365.
4.6 Harris JI, Hibbeln JR, Mackey RH, Muldoon MF. "Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients." Prostaglandins Leukot Essent Fatty Acids 2004; 71(4)263-269.
4.7 Muldoon MF, Mackey RH, Williams KV, Korytkowski MT, Flory JD, Manuck SB. "Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity." J Clin Endo Metab 2004; 89(1):266-271.
4.8 Bleil ME, McCaffery JM, Muldoon MF, Sutton-Tyrrell K, Manuck SB. "Anger-related personality traits and carotid artery atherosclerosis in untreated hypertensive men." Psychosom Med 2004;66:633-639.
4.9 Kamarck TW, Muldoon MF, Shiffman S, Sutton-Tyrrell K, Gwaltney C, Janicki DL. "Experiences of demand and control in daily life as correlates of subclinical carotid atherosclerosis in a healthy older sample." Health Psychol 2004;23:24-32.
4.10 Gianaros PJ, Bleil ME, Muldoon MF, Jennings JR, Sutton-Tyrrell K, McCaffery JM, Manuck SB. "Is cardiovascular reactivity associated with atherosclerosis among hypertensives?" Hypertension 2002;40:742-747.
4.11 Kamarck TW, Polk DE, Sutton-Tyrrell K, Muldoon MF. "The incremental value of ambulatory blood pressure persists after controlling for methodological confounds: associations with carotid atherosclerosis in a healthy sample." J Hypertens 2002;20:1535-1541.
4.12 Gianaros PJ, Jennings JR, Olafsson GB, Steptoe A, Sutton-Tyrrell K, Muldoon MF, Manuck SB. "Greater intima-media thickness in the carotid bulb is associated with reduced baroreflex sensitivity." Am J Hypertens 2002;15:486-491.
NATIONAL HEART, LUNG AND BLOOD INSTITUTE DYNAMIC REGISTRY
5.1 Abbot JD, Kip KE, Vlachos HA, Sawhney N, Srinivas VS, Jacobs AK, Holmes DR, Williams DO. "Lack of recent improvement in the percutaneous treatment of chronic total coronary occlusions." Am J Cardiology 2006. In Press.
5.2 Freeman AM, Abbott JD, Jacobs AK, Vlachos HA, Selzer F, Laskey WK, Detre KM, Williams DO. "Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus." J Interven Cardiol 2006. In Press.
5.3 Naidu SS, Polin GM, Selzer F, Laskey WK, Jacobs AK, Williams DO, Wilensky RL. "Despite advances in treatment percutaneous coronary intervention of unstable angina continues to be associated with a greater risk of complications compared to stable angina." Am J Cardiol 2006. In Press.
5.4 Holper EM, Blair J, Selzer F, Detre KM, Jacobs AK, Williams DO, Vlachos HA, Wilensky RL, Coady P, Faxon DP. "The impact of ejection fraction on outcomes after PCI in patients with congestive heart failure: an analysis of the NHLBI PTCA Registry and the Dynamic Registry." Am Heart J 2006. In Press.
5.5 Abbott JD, Choi EJ, Selzer F, Srinivas VS, Williams DO. "Impact of coronary collaterals on outcome following percutaneous coronary intervention (from the National Heart Lung and Blood Institute Dynamic Registry)." Am J Cardiol 2005;96:676-680.
5.6 Laskey WK, Selzer F, Jacobs AK, Cohen HA, Holmes DR Jr., Wilensky RL, Detre KM, Williams DO. "Major adverse clinical event rates following contemporary percutaneous coronary intervention: the importance of post-discharge follow-up." Am J Cardiol 2005;95:1135-1139.
5.7 Glaser R, Selzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, Detre KM, Wilensky RL. "Clinical progression of incidental asymptomatic lesions discovered during culprit vessel coronary intervention." Circulation 2005;111:152-158.
5.8 Laskey WK, Selzer F, Holmes DR Jr, Wilensky RL, Cohen HA, Williams DO, Kip KE, Detre K. "Temporal variation in in-hospital morality with percutaneous coronary intervention: A report from the National Heart, Lung, and Blood Dynamic Registry." Am Heart J 2005;150:569-576
5.9 Naidu SS, Vlachos H, Faxon D, Jacobs AK, Selzer F, Detre KM, Wilensky RL. "Non-coronary vascular disease predicts a higher adverse event rate following percutaneous coronary intervention." Am J Cardiol 2005;95:575-580.
5.10 Naidu SS, Selzer F, Jacobs AK, Faxon D, Marks DS, Johnston JM, Detre KM, Wilensky RL. "Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention: current results from the NHLBI Dynamic Registry." Am J Cardiol 2003;92: 1160-1164.
5.11 Slater J, Selzer F, Dorbala S, Tormey D, Vlachos HA, Wilensky RL, Jacobs AK, Laskey WK, Douglas JS Jr, Williams DO, Kelsey SF. "Ethnic differences in the presentation, treatment strategy and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry)." Am J Cardiol 2003; 92:773-778.
5.12 Cohen HA, Williams DO, Holmes DR Jr., Selzer F, Kip KE, Johnston JM, Holubkov R, Kelsey SF, Detre KM. "Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry." Am Heart J 2003;146:513-519.
5.13 Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM, Matthai WH Jr., Banka VS, Herrmann HC, Hirshfeld JW Jr., Kimmel SE, Kolansky DM, Horwitz PA, Schiele F, Bassand J-PL, Wilensky RL. "One-year clinical outcomes of protected and unprotected left main coronary artery stenting." Eur Heart J 2003;24:1554-1559.
5.14 Keelan PC, Johnston JM, Koru-Sengul T, Detre KM, Williams DO, Slater J, Block PC, Holmes DR. "Comparisons of in-hospital and one-year outcomes in patients with left ventricular ejection fractions 40%, 41-49% and 50% having percutaneous coronary revascularization." Am J Cardiol 2003;91:1168-1172.
5.15 Holmes DR Jr, Selzer F, Johnston J, Kelsey SF, Holubkov R, Cohen HA, Williams DO, Detre KM. "Modeling and risk prediction in the current era of interventional cardiology: a report from the NHLBI Dynamic Registry." Circulation 2003;107:1871-1876.
5.16 Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King SB, Holmes DR, Douglas J, Block P, Wilensky R, Williams DO, Detre KM. "Comparison of in-hospital and one year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (From the National Heart, Lung, and Blood Institute Dynamic Registry)." Am J Cardiol 2002; 90:1062-1067.
5.17 Holubkov R, Laskey WK, Haviland A, Slater JC, Bourassa MG, Vlachos HA, Cohen HA, Williams DO, Kelsey SF, Detre KM. "Angina one year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry." Am Heart J 2002;144:826-833.
5.18 Srivinas VS, Brooks MM, Detre KM, King SB, Jacobs AK, Johnston J, Williams DO. "Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study." Circulation 2002;106:1627-1633.
5.19 Bourassa MG, Detre KM, Johnston JM, Vlachos HA, Holubkov R. "Effect of prior revascularization on outcome following percutaneous coronary intervention." Eur Heart J 2002;23:1546-1555.
5.20 Wilensky RL, Selzer F, Johnston J, Laskey WK, Klugherz BD, Block P, Cohen H, Detre K, Willliams DO. "Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry)." Am J Cardiol 2002;90:216-221.
5.21 Holubkov R, Kennard ED, Foris JM, Kelsey SF, Soran O, Williams DO, Holmes DR, Jr. "Comparison of Patients Undergoing Enhanced External Counterpulsation and Percutaneous Coronary Intervention for Stable Angina Pectoris." Am J Cardiol 2002;89:1182-1186.
5.22 Jacobs, AK, Johnston JM, Haviland A, Brooks MM, Kelsey SF, Holmes DR, Faxon DP, Williams DO, Detre KM. "Improved Outcomes for Women Undergoing Contemporary Percutaneous Coronary Intervention: A Report from the National Heart, Lung, and Blood Institute Dynamic Registry." J Am Coll Cardiol 2002 39(10):1608-1614.
5.23 Al Suwaidi Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR. "Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI Dynamic Registry)." Am J Cardiol 2001;10(87):1139-1144.
5.24 Laskey WK, Williams DO, Vlachos HA, Cohen HA, Holmes Dr, King SB III, Kelsey SF, Slater J, Faxon D, Al-Bassam M, Block E, Detre KM. "Changes in the practice of percutaneous coronary intervention: A comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry". Am J Cardiol 2001;(87):964-969.
5.25 Al Suwaidi J, Yeh W, Williams DO, Laskey Wk, Cohen HA, Detre KM, Kelsey SF, Holems DR. "Comparison of immediate and one-year outcome after coronary angioplasty of narrowing <3mm with those >3mm (The National Heart, Lung, and Blood Institute Dynamic Registry)." Am J Cardiol 2001;(87):680-686
5.26 Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Cohen H, Cowley M, Dorros G, Faxon D, Holmes DR, Jacobs A, Kelsey SF, King SB, Myler R, Slater J, Stanek V, Vlachos HA, Detre KM, and Co-Investigators. "Percutaneous coronary intervention in the current era compared to 1985-86: The NHLBI Registries." Circulation 2000;2945-29951.
HEALTH PROMOTION AND DISEASE PREVENTION RESEARCH CENTERS
No publications at this time.
HEART FAILURE HOME CARE DEMONSTRATION PROJECT (HFHC)
No publications at this time.
IMPACT OF HIV ON HEPATITIS C INFECTION IN HEMOPHILIA (HEMOPHILIA)
8.1 Ragni MV, Belle SH. Impact of human immunodeficiency virus (HIV) infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C infection." Journal of Infectious Diseases 2001; 183(7):1112-1115.
INTERNATIONAL ENHANCED EXTERNAL COUNTERPULSATION PATIENT REGISTRY (IEPR)
9.1 Lawson WE, Silver MA, Hui JC, Kennard ED, Kelsey SF. "Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation." J Card Fail 2005 Feb;11(1):61-6.
9.2 Lawson WE, Hui JCK, Kennard ED, Barsness G, Kelsey SF. "Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus non-responders." Cardiology 2005;103:201-206.
9.3 Michaels AD, Barsness GW, Soran O, Kelsey SF, Kennard ED, Hui JCK, Lawson WE. "Frequency and Efficacy of Repeat Enhanced External Counterpulsation for Stable Angina Pectoris [From the International EECP Patient Registry (IEPR)]." Am J Cardiology 2005;95: 394-397.
9.4 Michaels AD, Linnemeier G, Soran O, Kelsey SF, Kennard ED. "Two year outcome after enhanced external counterpulsation for treatment of stable angina pectoris (from the International EECP Patient Registry [IEPR])." Am J. Cardiology 2004;93:461-464
9.5 Lawson WE, Hui JCK, Barsness G, Kennard ED, Kelsey SF. "Effectiveness of Enhanced External Counterpulsation in Patients with Left Main Disease and Angina." Clin. Cardiol 2004; 27:459-463.
9.6 Michaels AD, Linnemeier G, Soran O, Kelsey SF, Kennard ED. "Two year outcome after enhanced external counterpulsation for treatment of stable angina pectoris [From the International EECP Patient Registry (IEPR)]." Am J Cardiol 2004; 93:461-464.
9.7 Lawson WE, Hui JCK, Barsness GW, Kennard ED, Kelsey SF. "Effectiveness of enhanced external counterpulsation in patients with left main disease and angina." Clinical Cardiology 2004; 27:459-463.
9.8 Fitzgerald C, Lawson WE, Hui J, Kennard ED, Holubkov R. "Enhanced external counterpulsation as initial revascularization treatment for angina refractory to medical therapy." Cardiology 2003;100(3):129-135.
9.9 Linnemeier G, Rutter MK, Barsness G, Kennard ED, Nesto RW. "Enhanced external counterpulsation for the relief of angina inpatients with diabetes: safety, efficacy and one-year clinical outcomes." Am Heart J 2003; 146(3): 453-458.
9.10 Lawson W, Kennard E, Hui J, Holubkov R, Kelsey SF. "Predictors of successful response to Enhanced External Counterpulsation as treatment of angina pectoris" Am J Cardiol 2003; 92(4): 439-443.
9.11 Linnemeier G, Michaels AD, Soran O, Kennard E. "Enhanced external counterpulsation in the management of angina in the elderly." Am J Geriatri Cardiol 2003;12(2); 90-94.
9.12 Soran O, Kennard ED, Kelsey SF, Holubkov R, Strobeck J, Feldman AM. "Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: A report from the International EECP Patient Registry." CHF 2002; 8:297-302.
9.13 Lakshmi MV Kennard ED, Kelsey SF, Holubkov R, Michaels AD. "Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry (IEPR)." Am. J. Cardiol 2002; 89:1303- 1305.
9.14 Holubkov R, Kennard ED, Foris JM, Kelsey SF, Soran O, Williams D, Holmes DR,Jr. "A Comparison of Patients Undergoing Enhanced External Counterpulsation and Percutaneous Coronary Intervention for Stable Angina Pectoris." Am. J. Cardiol 2002; 89(10):1182-1186.
9.15 Holubkov R, Kennard ED, Kelsey SF, Soran O. "A report from the International Enhanced Counterpulsation Registry (IEPR)." in "Advances in Coronary Artery Disease." Edited by Basil Lewis, David A Halon, Moshe F. Flugelman, Jaromir Hradec (Bologna, Italy: Moduzzi Editore) 2001; 387-391.
9.16 Lawson W, Kennard ED, Holubkov R, Kelsey SF, Strobeck J, Soran O, Feldman A. "Benefit and Safety of Enhanced External Counterpulsation in Treating Coronary Artery Patients with a History of Congestive Heart Failure." Cardiology 2001; 96(2):78-84.
9.17 Barsness G, Feldman A, Holmes D, Holubkov R, Kelsey SF, Kennard ED. "The International EECP Patient Registry (IEPR): Design, methods, baseline characteristics, and acute results." Clinical Cardiology 2001; 24:435-442.
9.18 Michaels A, Kennard ED, Kelsey SK, Holubkov R, Soran O, Chou T. "Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation (EECP)?: Data from the international EECP patient registry (IEPR)." Clinical Cardiology 2001; 24:453-458.
KNEE STABILITY TRAINING IN INDIVIDUALS WITH KNEE OA
No publications at this time.
LONGITITUDINAL ASSESSMENT OF BARIATRIC SURGERY (LABS)
No publications at this time.
PEDIATRIC ACUTE LIVER FAILURE (PALF)
No publications at this time.
RANDOMIZED CLINICAL TRIAL ON PREVENTING PRESSURE ULCERS WITH SEAT CUSHIONS
No publications at this time.
RHEUMATIC DISEASES CORE CENTER: BIOSTATISTICS CORE (RDCC)
14.1 Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB. "Obesity, regional body fat distribution and the Metabolic Syndrome in older men and women." Archives of Internal Medicine 2005;165:777-783.
14.2 Manzi S, Navratil JS, Ruffing, MJ, Liu CC, Danchenko N, Nilson SE, Krishnaswami S, King DES, Kao AH, Ahearn JM. "Measurement of erythrocyte C4d and complement receptor 1 in systemic Lupus Erythematosus." Arthritis & Rheumatism 2004;50(11): 3596-3604.
RESOURCES FOR ENHANCING ALZHEIMER'S CAREGIVER HEALTH (REACH II)
15.1 Czaja SJ, Schulz R, Belle SH, Burgio LD, Armstrong N, Gitlin LN, Coon DW, Martindale-Adams J, Klinger J, Stahl SM. "Data safety monitoring in social behavioral intervention trials: The REACH II experience." Clinical Trials 2005. In Press.
RESEARCH EVALUATING THE VALUE OF AUGMENTING MEDICATION WITH PSYCHOTHERAPY (REVAMP)
No publications at this time.
RITUXIMAB IN THE TREATMENT OF REFRACTORY ADULT AND JUVENILE DERMATOMYOSITIS AND POLYMYOSITIS
No publications at this time.
SPECIALIZED CENTER OF CLINICALLY ORIENTED RESEARCH (SCCOR) BIOSTATISTICS AND DATA MANAGEMENT CORE
No publications at this time.
SEQUENCED TREATMENT ALTERNATIVES TO RELIEVE DEPRESSION (STAR*D)
19.1 Trivedi MH Rush AJ, Wisniewski SR, Nierenberg NN, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GH, and Fava M for the STAR*D Study Team. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice." American Journal of Psychiatry 2006;163:28-40.
19.2 Pilowski DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Wisniewski SR, Trivedi MH, Talati A, Carlson MM, Liu HH, Fava M, Weissman MM. "Children of Currently Depressed Mothers: A STAR*D Ancillary Study." Journal of Clinical Psychiatry 2006;67:126-136.
19.3 Hollon SD, Shelton RC, Wisniewski SR, Warden D, Biggs MM, Friedman E, Husain M, Kupfer DJ, Nierenberg AA, Petersen TJ, Shores-Wilson K, Rush AJ. "Presenting Characteristics of Depressed Outpatients as a Function of Recurrence: Preliminary Findings from the STAR*D Clinical Trial." Journal of Psychiatric Research 2006;40:59-69.
19.4 Trivedi MH, Rush AJ, Wisniewski SR, Warden D, McKinney W, Downing M, Berman SR, Farabaugh A, Luther JF, Nierenberg AA, Lis J, SackeimH. "Factors Associated with Heath-Related Quality of Life Among Outpatients with Major Depressive Disorder: A STARD Report." Journal of Clinical Psychiatry 2006;67:185-195.
19.5 Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg A, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ for the STAR*D Study Team. "A Comparison of Citalopram Augmentation with Bupropion-SR and Buspirone Following SSRI Failure for Depressed Outpatients: A STAR*D Report." New England Journal of Medicine 2006;354:1243-1252 .
19.6 Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg A, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M for the STAR*D Team. "A Comparison of Bupropion-SR, Sertraline, and Venlafaxine-XR Following SSRI Failure for Depressed Outpatients: A STAR*D Report." New England Journal of Medicine 2006;354:1231-1242.
19.7 Alpert JE, Biggs MM, Davis L, Shores-Wilson K, Harlan W, Schneider G, Ford AL, Farabaugh A, Stegman D, Ritz A, Husain M, Macleod L, Wisniewski SR, Rush AJ for the STAR*D Investigators. "Enrolling Research Subjects from Clinical Practice: Ethical and Procedural Issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial." Psychiatry Research 2006;141:193-200.
19.8 Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ for the STAR*D-Child Team. "Remission in Maternal Depression and Child Psychopathology: A STAR*D-Child Report." Journal of the American Medical Association 2006;295:1389-1398.
19.9 Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA for the STAR*D Investigators. "Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects." Journal of Psychiatric Practice 2006;12:71-79.
19.10 Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. "Characteristics of insured and non-insured depressed outpatients: Preliminary findings from STAR*D." Psychiatric Services 2005;56:995-1004.
19.11 Novick JS, Stewart JW, Wisniewski SR, Cook A, Manev R, Nierenberg A, Rosenbaum J, Shores-Wilson K, Balasubramani GK, Biggs MM, Zisook S, Rush AJ for the STAR*D Investigators. "Clinical and demographic features of atypical depression in outpatients with major depression: Preliminary findings from STAR*D." Journal of Clinical Psychiatry 2005;66:1002-1011.
19.12 Gaynes BN, Davis L, Rush AJ, Trivedi M, Fava M, Wisniewski SR. "The aims and design of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study." Primary Psychiatry 2005;12:36-41.
19.13 Husain MM, Rush AJ, Sackeim HA, Wisniewski SR, McClintock SM, Craven N, Holiner J, Mitchell JR, Balasubramani GK, Hauger R. "Age-related characteristics of depression: A preliminary STAR*D report." American Journal of Geriatric Psychiatry 2005;13:852-860.
19.14 Warden D, Rush AJ, Ritz L, Trivedi MH, Stegman D, Wisniewski SR. "Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D." Controlled Clinical Trials 2005;26:95-112.
19.15 Gaynes BN, Rush AJ, Trivedi M, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Schneider RK, Castro DB, Golden RN. "A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial." General Hospital Psychiatry 2005;27:87-96.
19.16 Kornstein SG, Harvey AT, Rush AJ, Wisniewski SR, Trivedi MH, Svikis DS, McKenzie ND, Harley BC. "Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression." Psychological Medicine 2005;35:683-692.
19.17 Perlis RH, Fraguas R, Bankier B, Fava M, Trivedi M, Luther JF, Wisniewski SR, Rush AJ. "Prevalence and clinical correlates of irritability in major depressive disorder: A preliminary report from STAR*D." Journal of Clinical Psychiatry 2005;66:159-166.
19.18 Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, Wisniewski SR, Balasubramani GK, Trivedi MH, Rush AJ. "Gender differences in depression: Findings from the STAR*D study." Journal of Affective Disorders 2005;87:141-150.
19.19 Davis LL, Rush AJ, Wisniewski SR, Rice K, Cassano P, Jewell ME, Biggs MM, Shores-Wilson K, Balasubramani GK, Husain MM, Quitkin FM, McGrath PJ. "Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the STAR*D cohort." Comprehensive Psychiatry 2005;46:81-89.
19.20 Zisook S, Rush AJ, Albala A, Alpert J, Balasubramani GK, Fava M, Husain M, Sackeim H, Trivedi M, Wisniewski SR. "Factors that differentiate early vs. later onset of major depressive disorder." Psychiatry Research 2004;19:127-140.
19.21 Friedman EF, Thase, ME, Biggs MM, Carmin C, Hollon SD, Kornblith SJ, Petersen T, Veenstra G, Wisniewski SR, Rush,AJ. "The implementation of cognitive therapy in STAR*D." Cognitive Therapy and Research 2004;28:819-833.
19.22 Yates WR, Mitchell J, Rush AJ, Trivedi M, Wisniewski SR, Warden D, Hauger RB, Fava M, Gaines BN, Husain M, Bryan C. " Clinical features of depressed outpatients with and without general medical conditions in STAR*D." General Hospital Psychiatry 2004;26:421-429.
19.23 Nierenberg AA, Trivedi MH, Ritz L, Burroughs D, Greist J, Sackeim H, Kornstein S, Schwartz T, Stegman D, Fava M, Wisniewski SR. "Suicide risk management for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study: Applied NIMH guidelines." Journal of Psychiatric Research 2004;38:583-589.
19.24 Wisniewski SR, Eng H, Meloro L, Gatt R, Ritz L, Stegman D, Trivedi M, Biggs MM, Friedman E, Shores-Wilson K, Warden D, Bartolowits D, Martin JP and Rush AJ. "Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project." Clinical Trials 2004;1:387-398.
19.25 Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ. "Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D." Psychological Medicine 2004;34:1299-1308.
19.26 Wisniewski SR, Stegman D, Trivedi M, Husain MM, Eng H, Shores-Wilson K, Luther J, Biggs MM, Burroughs D, Ritz AL, Fava M, Quitkin F, Rush AJ for the STAR*D Investigators. "Methods of testing feasibility for Sequenced Treatment Alternatives to Relieve Depression (STAR*D)." Journal of Psychiatric Research 2004;38(3):241-248.
19.27 Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi M, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart J, McGrath PJ, Biggs, MM, Shores-Wilson K, O'Neal BL, Lebowitz BD, Ritz AL, Niederehe G for the STAR*D Investigators Group. "Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and Design." Controlled Clinical Trials 2004;25(1):119-142.
19.28 Rush AJ, Trivedi M, Fava M. "Depression IV: STAR*D treatment trial for depression." [Images in Neuroscience]. American Journal of Psychiatry 2003;160:237.
19.29 Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski SR, Lavori PW, Rosenbaum JF, Kupfer DJ for the STAR*D Investigators. "Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study in The Psychiatric Clinics of North America." Rosenbaum JF & Dunner DL (Eds.). W.B. Saunders Company, Philadelphia, 2003.
19.30 Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenbert A, Quitkin FM, Sacheim HA, Thase ME, Trivedi M for the STAR*D Group. "Strengthening clinical effectiveness trials: Equipoise-stratified randomization." Biological Psychiatry 2001;50:792-801.
COORDINATING CENTER: STUDY OF WOMEN'S HEALTH ACROSS THE NATION (SWAN)
20.1 Gold E, Colvin A, Avis N, Bromberger J, Greendale G, Powell L, Sternfeld B, Matthews K. "Longitudinal Analysis of Vasomotor Symptoms and Race/Ethnicity Across the Menopausal Transition: Study of Women's Health Across the Nation (SWAN)." American Journal of Public Health 2005. Accepted.
20.2 Avis N, Brockwell S, Colvin A. "A Universal Menopause Syndrome?" American Journal of Medicine 2005;118(12):37-46.
20.3 Randolph JF, Sowe rs MF, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA. "The Relationship of Longitudinal Change in Reproductive Hormones and Vasomotor Symptoms during the Menopausal Transition." The Journal of Clinical Endocrinology and Metabolism 2005;90(11):6106-6112.
20.4 Sowers MR, Matthews KA, Jannausch M, Randolph JF, McConnell D, Sutton-Tyrrell K, Little R, Lasley B, Pasternak R. "Hemostatic Factors and Estrogen during the Menopausal Transition." The Journal of Clinical Endocrinology & Metabolism 2005;90(11):5942-5948.
20.5 Sowers MR, Jannausch M, Randolph JF, McConnell D, Little R, Lasley B, Pasternak R, Sutton-Tyrrell K, Matthews K. "Androgens Are Associated with Hemostatic and Inflammatory Factors among Women at the Mid-Life." The Journal of Clinical Endocrinology & Metabolism 2005;90(11):6064-6071.
20.6 Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, Matthews KA, Pasternak RC, Everson-Rose SA, Scuteri A, Chae CU. "Ethnic Variation in Hypertension Among Premenopausal and Perimenopausal Women: Study of Women's Health Across the Nation." Hypertension 2005;46:1-7.
20.7 Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. "Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN)." Menopause 2005;12(4):385-398.
20.8 Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF, Schocken M, Skurnick J, Ory MG, Sutton-Tyrrell K. "Ethnic Differences in Past Hysterectomy for Benign Conditions." Women's Health Issues 2005;15(4):179-186.
20.9 Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton-Tyrrell K. "Coronary and Aortic Calcification in Women With a History of Major Depression." Archive of Internal Medicine 2005;165(11):1229-1239.
20.10 Sutton-Tyrrell K, Wildman R, Matthews K, Chae CU, Lasley B, Brockwell S, Pasternak R, Lloyd-Jones DM, Sowers MF. "Sex hormone binding globulin and the free androgen index are related to CV risk factors in multi-ethnic premenopausal and perimenopausal women enrolled in The Study of Women's Health Across the Nation (SWAN)." Circulation 2005;111:1242-1249.
20.11 Avis NE, Ory M, Matthews KA, Schocken M, Colvin AB. "Health-related quality of life in a multi-ethnic sample of middle-aged women: Results from the Study of Women's Health Across the Nation (SWAN)." Medical Care 2003; 41: 1262-1276.
20.12 Troxel WM, Matthews KA, Bromberger JT, Sutton-Tyrrell K. "Chronic stress burden, discrimination, and subclinical carotid artery disease in African American and Caucasian Women." Health Psychol 2003;22(3):300-309.
20.13 Kravitz HM, Ganz PA, Sherman S, Bromberger JT, Powell LH, Sutton-Tyrrell K, Meyer PM. "Sleep difficulty in women at midlife: A community survey of sleep and the menopausal transition." Menopause 2003; 10(1):19-28.
20.14 Jones DJ, Matthews KA, Bromberger JT, Sutton-Tyrrell K. "Lifetime history of depression and carotid atherosclerosis in middle-aged women." Archives of General Psychiatry 2002; 60:153-160.
20.15 Bromberger JT, Meyer P, Kravitz H, Sommer B, Cordal A, Powell L, Ganz P, Sutton-Tyrrell K. "Psychological distress and natural menopause: A Multi-ethnic community study." American Journal of Public Health 2001;91:1435-1442.
PREVALENCE AND PROGRESSION OF SUBCLINICAL ATHEROSCLEROSIS THROUGH THE MENOPAUSAL TRANSITION (SWAN Heart)
21.1 Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chan Y-F, Sutton-Tyrrell K. "Coronary and aortic calcification in women with major depression history." Arch Intern Med 2005;165:1229-1236.
EPIDEMIOLOGY ULTRASOUND RESEARCH LABORATORY (URL)
22.1 Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. "Differences in lipoprotein subclasses and coronary artery calcification by hormone replacement therapy use, the Healthy Women Study." Arch Intern Med 2005;165:510-15.
22.2 Sekikawa A, Ueshima H, Zaky WR, Kadowaki T, Edmundowicz D, Okamura T, Sutton-Tyrrell K, Nakamura Y, Egawa K, Kanda H, Kashiwagi A, Kita Y Maegawa H, Mitsunami K, Murata K, Nishio Y, Tamaki S, Ueno Y, Kuller LH. "Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors." International Journal of Epidemiology 2005;34:173-179.
22.3 Patel AS, Mackey RH, Wildman RP, Thompson T, Matthews K, Kuller L, Sutton-Tyrrell K. "Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women." Atherosclerosis 2005;178:311-317.
22.4 Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. "Hormone Therapy, Lipoprotein Subclasses, and Coronary Calcification." Arch Intern Med 2005;165:510-515.
22.5 Gungor N, Thompson T, Sutton-Tyrrell K, Janosky J, Arslanian S. "Early signs of cardiovascular disease in youth with obesity and Type 2 diabetes." Diabetes Care 2005;28:1219-1221.
22.6 Wildman RP, Muntner P, Chen J, Sutton-Tyrrell KS, He J. "Relation of Inflammation to Peripheral Arterial Disease in the National Health and Nutrition Examination Survey, 1999-2002." Am J Cardiol 2005;96:1579-1583.
22.7 Sutton-Tyrrell K, Najjar SS, Kupelian V, Simonsick EM, Havlik R, Lakatta E, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, Venkitachalam L, Boudreau R for the Health ABC Study. "Elevated aPWV, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults." Circulation 2005;111:3384-3390.
22.8 Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, van der Veen F, Meltzer CC. "Reduced cerebral blood flow response and compensation among untreated hypertensives." Neurology 2005;64:1358-1365
22.9 Matthews KA, Sutton Tyrrell K. "Trait Anger and the Metabolic Syndrome Predict Progression of carotid atherosclerosis in healthy middle-aged women." Psycho Med 2004;66(6):903-8.
22.10 Matthews KA, Raikkonen K, Sutton-Tyrrell K, Kuller LH. "Optimistic attitudes protect against progression of carotid atherosclerosis in health middle-aged women" Psychoso Med 2004; 66(5):640-4.
22.11 Kamarck TW, Muldoon MF, Shiffman S, Sutton-Tyrrell K, Gwaltney C, Janicki DL. "Experiences of demand and control in daily life as correlates of subclinical carotid atherosclerosis in a healthy older sample." Health Psychol 2004;23(1):24-32.
22.12 Schott LL, Wildman RP, Brockwell S, Simkin-Silverman LR, Kuller LH, Sutton-Tyrrell K. "Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife." Arterioscler Thromb Vasc Biol 2004;24(10):1951-1956.
22.13 Wildman RP, Schott LL, Brockwell S, Kuller LH, Sutton-Tyrrell K. "A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis." J Am Coll Cardiol 2004;44:579-585.
22.14 Loehr LR, Espeland MA, Sutton-Tyrrell K, Burke GL, Crouse JR III, Herrington DM. "Racial differences in endothelial function in postmenopausal women." Am Heart J 2004;148:606-611.
22.15 Ding J, Visser M, Kritchevsky SB, Nevitt M, Newman A, Sutton-Tyrrell K, Harris TB. "The association of regional fat depots with hypertension in older persons of White and African American ethnicity." Am J Hypertens 2004;17:971-976.
22.16 Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, Manzi S. "Comparison of risk factors for vascular disease in the carotid artery in women with systemic Lupus erythematosus." Arthritis Rheum 2004;50(1): 151-159.
22.17 Kamarck TW, Polk DE, Sutton-Tyrrell K, Muldoon MF. "The incremental value of ambulatory BP persists after controlling for methodological confounds: associations with carotid arthrosclerosis in a health sample." J Hypertension 2003;20(8): 1535-1541.
22.18 Cesari M, Penninx BWJH, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Tracy RP, Harris TB, Pahor M. "Inflammatory markers and cardiovascular disease: Results from the Health, Aging and Body Composition (Health ABC) study." Am J Cardiol 2003;92(5):522-528.
22.19 Cao JJ, Thacdh C, Manolino TA, Psaty BM, Kuller LH, Chaves PHM, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M. "C-Reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health Study." Circulation 2003;108:166-170.
22.20 Havlik RJ, Simonsick EM, Sutton-Tyrrell K, Newman A, Danielson ME, Brock DB, Pahor M, Lakatta E, Spurgeon H, Vaitkeviciusm for the Health ABC Investigators. "Association of physical activity and vascular stiffness in 70 to 79 year olds: The Health ABC Study." Journal of Aging and Physical Activity 2003;11:156-166.
22.21 Sekikawa A, Okamura T, Kadowaki T, Mitsunami K, Murata K, Kashiwagi A, Nakamura Y, Kanda, Edmundowicz D, Sutton-Tyrrell K, Curb JD, Kuller LH, Ueshima H. "Electron beam computed tomography for identification of high-risk persons in primary prevention of coronary heart disease in the United States and its implication for Japan." Japanese J Pub Health 2003;50(3):183-193.
22.22 Sekikawa A, Horiuchi BY, Edmundowicz D, Ueshima H, Curb JD, Sutton-Tyrrell K, Okamura T, Kadowaki T, Kashiwagi A, Mitsunami K, Murata K, Nakamura Y, Rodriguez BL, Kuller LH. "A 'natural experiment' in cardiovascular epidemiology in the early 21st century." Heart 2003; 89:255-257.
22.23 Newman AB, Naydeck BL, Whittle J, Sutton-Tyrrell K, Edmundowicz D, Kuller LH. "Racial differences in coronary artery calcification in older adults (older blacks have a lower extent of coronary artery calcium)." Arteros Thromb Vasc Biol 2002;22:424-430.
22.24 Newman AB, Naydeck BL, Sutton-Tyrrell K, Edmundowicz D, O'Leary D, Kronmal R, Burke GL, Kuller LH. "Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults." Arterioscler Thromb Vasc Biol 2002;22:1674-1679.
22.25 Olson JC, Erbey JR, Williams KV, Becker DJ, Edmundowicz D, Kelsey SF, Sutton-Tyrrell K, Orchard TJ. "Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in Type 1 Diabetes." An Epidemiol 2002;12:331-337.
22.26 Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, Sakkinen P, Lyles M, Spurgeon HA, Kuller LH, Lakatta E. "Aortic stiffness is associated with measures of insulin and glucose in an elderly subgroup of the cardiovascular health study." Am J Hypertension 2002;15:16-23.
22.27 Bromberger JT, Meyer PM, Kravitz HM, Sommer B, Cordal A, Powell L, Ganz PA., Sutton-Tyrrell K. "Psychological distress and natural menopause: A multi-ethnic community study." Am J Public Health 2001; 91(9):1435-1442.
22.28 Sutton-Tyrrell K, Newman AB, Simonsick E, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P for the health investigators. "Aortic stiffness is associated with visceral adiposity in older adults enrolled in Health ABC." Hypertension 2001;38(3):429-433.
22.29 Sutton-Tyrrell K, Mackey RH, Holubkov R, Vaitkevicius PV, Spurgeon HA, Lakatta EG. "Measurement variation of aortic pulse wave velocity." Am J Hypertension 2001;14:463-468.
22.30 Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. "Vascular stiffness in women with systemic lupus erythematosus." Hypertension 2001;37:1075-1082.
22.31 Thompson T, Sutton-Tyrrell K, Wildman R. "Continuous quality assessment programs can improve carotid duplex scan quality." J Vasc Technology 2001;25(1):33-39.
22.32 Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. "Coronary artery calcification in older adults to age 99: Prevalence and risk factors." Circulation 2001;104:2679-2684.
22.33 Talbot EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS. "Cardiovascular risk in women with polycystic ovary syndrome. Obstretrics and Gynecology Clinics of North America 2001;28:111-133.
22.34 Newman AB, Naydeck BL, Sutton-Tyrrell K, Edmundowicz D, Gottdiener J, Kuller LH. "Coronary artery calcification in older adults with minimal clinical or subclinical cardiovascular disease." J Am Geriatr Soc 2000;48:256-263
22.35 Talbot EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH. "Evidence for an association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women." ATVB 2000;20:2414-2421.
22.36 Manzi S, Kuller LH, Edmundowicz D, Sutton-Tyrrell K. "Vascular imaging: Changing the face of cardiovascular research." Lupus 2000;9:176-182.
22.37 Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH. "Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus." Arthritis & Rheumatism 1999;42:51-60.
22.38 Kuller LH, Sutton-Tyrrell K. "Aging and cardiovascular disease, Use of subclinical measurements Cardiovascular Disease in the Elderly." Cardiology Clinics February 1999;17(1):51-65.
22.39 Kuller LH, Matthews KA, Sutton-Tyrrell K, Edmundowicz D, Bunker CH. "Coronary and aortic calcification among women eight years postmenopause and premenopausal risk factors: The Healthy Women Study." Arterio Thromb Vasc Biol 1999;19:2189-2198.
22.40 Kuller LH, Sutton-Tyrrell K, Matthews KA. "Blood pressure levels and measurement of subclinical vascular disease." Journal of Hypertension 1999;17(5):S15-S19.
22.41 Naydeck BL, Sutton-Tyrrell K, Schiller KD, Newman AB, Kuller LH. "Prevalence and risk factors for abdominal aortic aneurysms in older adults with and without isolated systolic hypertension." Am J Cardiol 1999;83:759-764.
22.42 Jennings JR, Muldoon MF, Ryan C, Mintun M, Meltzer C, Townsent D, Sutton-Tyrrell K, Shapiro AP, Manuck SB. "Cerebral blood flow in hypertensives: An initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks." Hypertension 1998;31:1216-1222.
22.43 Sutton-Tyrrell K, Zeigler-Johnson C, Lassila HC, Holmes J, Kuller LH. "Racial differences in carotid atherosclerosis among premenopausal and postmenopausal women." J Cardiovasc Dis Prevention 1998;1:39-47.
22.44 Zeigler-Johnson CM, Holmes JL, Lassila HC, Sutton-Tyrrell K, Kuller LH. "Subclinical atherosclerosis in relation to hysterectomy status in African-American women." Stroke 1998;29:759-764.
22.45 Matthews KA, Owens JF, Kuller LH, Sutton-Tyrrell K, Lassila HC, Wolfson SK. "Mental stress-induced changes in pulse pressure predicts carotid atherosclerosis in healthy postmenopausal women." Stroke 1998;29:1525-1530.
22.46 Newman AB, Sutton-Tyrrell K, Kuller LH. "Mortality over four years in SHEP participants with a low ankle-arm index." J Am Geriatr Soc 1997;45:1472-1478.
22.47 Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson SK. "Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study." Journal of Obstetrics and Gynecology 1996;174:1224-1232.
22.48 Alcorn H, Wolfson S, Sutton-Tyrrell K, and Kuller L. "Abdominal aortic aneurysms in the cardiovascular health study"Arterioscler,Thromb,VascBiol 1996;16:963-970.
STUDY OF VIRAL RESISTANCE TO ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C (VIRAHEP-C) COORDINATING CENTER
23.1 Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD. "Peginterferon Alfa-2a and Ribavirin in African American and Caucasian Patients with Chronic Hepatitis C, Genotype 1." Hepatology 2005;4(42):275A.
23.2 Howell C, Dowling T, Jeffers L, Terrault N, Wiley-Lucas T, Haritos M. "Peginterferon alfa-2a Pharmacokinetics in African Americans and Caucasians infected with HCV genotype 1." Hepatology 2005;4(42):658A.
23.3 Kelley S, Cline J, Lawlor S, Smith S. "Development of a retention protocol to target participant subgroups in a multi-center clinical trial." Controlled Clinical Trials 2005;1(2):S80.
23.4 Conjeevaram HS, Kleiner DE, Everhart JE, Afdhal N, Brown RS, Fried MW, Howell CD, Jeffers LJ, Terrault N, Wiley TE, Cherry CR, Wahed AS. "Race, insulin resistance, visceral adiposity and hepatic steatosis in patients with chronic hepatitis C." Hepatology 2004;4(40):443A.
23.5 Rosen HR, Weston SJ, Im K, Belle SH. "Ethnicity and the cellular immune response in patients with chronic hepatitis C genotype 1 infection." Hepatology 2004;4(40):178A.
23.6 Belle SH, Conjeevaram HS, Jeffers LJ. "Racial differences in patients with hepatitis C genotype 1." Hepatology 2003;4(38):309A.
23.7 Conjeevaram HS, Kleiner DE, Afdhal N, Brown RS, Fried MW, Howell CD, Jeffers LJ, Terrault N, Wiley TE, Cherry C, Belle SH, Hoofnagle JH. "Race, insulin resistance, visceral adiposity and hepatic steatosis in genotype 1 patients with chronic hepatitis C." Hepatology 2003;4(38):347A.
23.8 Lawlor S, Cai C, Kelley S, Belle S. "An automated serious adverse event reporting system." Controlled Clinical Trials 2003;3(24):46S-47S.
23.9 Lawlor S, Kelley S, Belle S. "Self-assessments using touch screen technology." Controlled Clinical Trials 2003;3(24):119S.
23.10 Scott SR, Belle SH, Brown RS, Theodore D, Fried MW. "Baseline psychosocial characteristics of participants in the Virahep-C study." Hepatology 2003;4(38):313A.
WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE)
24.1 Shaw LJ, Bairey Merz CN, Reis SE, Bittner V, Kelsey SF, Olson MB, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyami AA, Sopko G. "Ischemic Heart Disease in Women: Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Part I: Sex Differences in Traditional and Novel Risk Factors, Symptom Evaluation and Gender-Optimized Diagnostic Strategies." Journal of the American College of Cardiology 2006. In Press.
24.2 Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson MB, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyami AA, Sopko G. "Ischemic Heart Disease in Women: Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Part II: The Role of Micro- and Macrovascular Disease Affecting Gender Differences in Presentation, Diagnosis and Outcome." Journal of the American College of Cardiology 2006. In Press.
24.3 Shaw LJ, Olson MB, Kip KE, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN. "The Value of Estimated Functional Capacity in Estimating Outcome: Results from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation." Journal of the American College of Cardiology 2006. In Press.
24.4 Handberg E, Johnson BD, Arant CB, Wessel TR, Kerensky RA, von Mering GO, Olson MB, Reis SE, Shaw LJ, Bairey Merz CN, Sharaf BL, Sopko G, Pepine CJ. "Impaired Coronary Vascular Reactivity and Functional Capacity in Women: Results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)." Journal of the American College of Cardiology 2006. In Press.
24.5 Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, Shaw LJ, Mankad S, Pepine CJ, Reis SE, Rogers WJ, Sharaf BL, Sopko G. "Hypertension, Menopause and Coronary Artery Disease Risk in the Women's Ischemia Syndrome Evaluation (WISE) Study." Journal of the American College of Cardiology 2006. In Press.
24.6 Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Bairey Merz CN, Sopko G, Cornell C, Sharaf BL, Matthews K. "Depression Symptoms are Associated with Increased CAD Risk and Mortality Among Women with Suspected Coronary Disease: The NHLBI-Sponsored WISE Study." Psychosomatic Medicine 2006. In Press.
24.7 Olson MB, Krantz DS, Kelsey SF, Pepine CJ, Sopko G, Handberg E, Rogers WJ, Gierach GL, McClure CK, Bairey Merz CN. "Hostility Scores are Associated with Increased Risk of Cardiovascular Events in Women Undergoing Coronary Angiography: A Report from the NHLBI-Sponsored WISE Study." Psychosomatic Medicine 2005;67:546-552.
24.8 Terra SG, McGorray SP, McNamara DM, Cavallari LH, Walker J, Wallace MR, Johnson BD, Bairey Merz CN, Sopko G, Pepine CJ, Johnson JA. "Association Between ?-Adrenergic Receptor Polymorphisms and Their G-Protein Coupled Receptors with Body Mass Index and Obesity in Women: A Report from the NHLBI-Sponsored WISE Study." International Journal of Obesity 2005:1-9.
24.9 Kip KE, Marroquin OC, Shaw LJ, Arant CB, Wessel TR, Olson MB, Johnson BD, Mulukutla S, Sopko G, Bairey Merz CN, Reis SE. "Global Inflammation Predicts Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) Study." American Heart Journal 2005;150:900-906.
24.10 Marroquin OC, Kip K, Mulukutla S, Ridker P, Pepine C, Tjandrawan T, Kelsey SF, Mankad S, Rogers W, Bairey Merz CN, Sopko G, Sharaf B, Reis SE. "Inflammation, endothelial cell activation and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease." American Heart Journal 2005;150:109-115.
24.11 Triola B, Olson MB, Reis SE, Rautaharju R, Bairey Merz CN, Kelsey SF, Shaw LJ, Sharaf BL, Sopko G, Saba S. "Electrocardiographic predictors of cardiovascular outcomes in women: The NHLBI-sponsored WISE study." Journal of the American College of Cardiology 2005;46:51-56.
24.12 Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine C, Mankad S, Rogers W, Bairey Merz CN, Sopko G, Cornell C, Sharaf B, Matthews K. "Social networks are associated with lower coronary disease risk and mortality rates among women with chest pain: the WISE study." Psychosomatic Medicine 2004; 66(6):882-888.
24.13 Wessel TR, Arant CB, Olson MB, Johnson BD, Reis SE, Sharaf BL, Shaw LJ, Handberg E, Sopko G, Kelsey SF, Pepine CJ, Bairey Merz CN. "Relationship between physical fitness versus body mass index with coronary artery disease and cardiovascular events in women: Results of the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)." JAMA 2004;292:1179-1187.
24.14 Johnson BD, Bairey Merz CN, Braunstein GD, Berga SL, Bittner V, Hodgson TK, Gierach GL, Reis SE, Vido DA, Sharaf BL, Smith KM, Sopko G, Kelsey SF. "Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study." J Women's Health 2004;13:872-887.
24.15 Morise AP, Olson MB, Bairey Merz CN, Mankad S, Rogers WJ, Pepine CJ, Reis SE, Sharaf BL, Sopko G, Smith K, Pohost GM, Shaw L. "Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study." American Heart J 2004;147:1085-1092.
24.16 Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM. "Prognosis in women with myocardial ischemia in the absence of coronary disease: results from the NIH-NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)." Circulation 2004;109:2993-2999.
24.17 Olson MB, Bairey Merz CN, Shaw LJ, Mankad S, Reis SE, Pohost GM, Smith KM, McGorray SP, Cornell CE, Kelsey SF. "Hormone replacement, race, and psychological health in women: a report from the NHLBI-sponsored WISE study." J Women's Health 2004;13:325-332.
24.18 Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ, Sharaf BL, Reis SE, Smith KM, Johnson BD, Handberg E, Mankad S, Pepine CJ. "Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: Results from the NHLBI WISE study." JACC 2004;43:2009-2014.
24.19 Johnson BD, Kip K, Marroquin O, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf BL, Bairey Merz CN, Sopko G, Olson MB, Reis SE. "Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. The National Heart, Lung, and Blood Institute - sponsored Women's Ischemia Syndrome Evaluation (WISE)." Circulation 2004;109:726-732.
24.20 Von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, Smith KM, Olson MB, Johnson BD, Sopko G, Handberg E, Pepine CJ, Kerensky RA. "Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute - sponsored Women's Ischemia Syndrome Evaluation (WISE)." Circulation 2004;109:722-725.
24.21 Marroquin OC, Kip KE, Kelley D, Johnson BD, Shaw L, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE. "Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation." Circulation 2004;109:714-721.
24.22 Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. "Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study." Circulation 2004;109:706-713.
24.23 Pepine CJ, Balaban RS, Bnow RO, Diamond GA, Johnson BD, Johnson PA, Mosca L, Nissen SE, Pohost GM. "Women's Ischemic Syndrome Evaluation. Current status and future research directions. Report of the National Heart, Lung and Blood Institute workshop, October 2-4, 2002. Section 1: Diagnosis of stable ischemia and ischemic heart disease." Circulation 2004;109: e44-e46.
24.24 Shaw LJ, Lewis JF, Hlatky MA, Hsueh WA, Kelsey SF, Klein R, Manolio TA, Sharrett AR, Tracy RP. "Women's Ischemic Syndrome Evaluation. Current status and future research directions. Report of the National Heart, Lung and Blood Institute workshop, October 2-4, 2002. Section 5: Gender-related risk factors for ischemic heart disease." Circulation 2004;109: e44-e46.
24.25 Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers WJ, Pohost GM, Kelsey SF. "Hypoestrogenemia of hypothalamic origin is associated with coronary artery disease in postmenopausal women: the WISE study." Proceedings of the 5th International Congress on Coronary Artery Disease 2003; pp 151-155.
24.26 Johnson BD, Kelsey SF, Bairey Merz CN. "Clinical risk assessment in women. Chest discomfort: report from the WISE study." Chapter 10 in L. Shaw, R. Redberg (Eds.). Coronary Disease in Women: Evidence-Based Diagnosis and Treatment. Totowa NJ: Humana Press 2003; pp 129-141.
24.27 Shaw LJ, Johnson BD, Mulvagh S, Mieres JH, Redberg R, Bairey Merz CN. "State of the art diagnostic testing in women: a research update." Chapter 13 in L. Shaw, R. Redberg (Eds.), Coronary Disease in Women: Evidence-Based Diagnosis and Treatment. Totowa NJ: Humana Press 2003; pp 129-141.
24.28 Olson MB, Kelsey SF, Matthews KA Shaw LJ, Sharaf BL, Pohost GM, Cornell CE, McGorray SP, Vido D, Bairey Merz CN. "Symptoms, myocardial ischemia and quality of life in women: results from the NHLBI-sponsored WISE study." European Heart Journal 2003; 24(16): 1506- 1514.
24.29 Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Bairey Merz CN, Sopko G, Cornell CE, Matthews KA. "Socioeconomic status predicts cardiovascular disease risk factors and prospective mortality incidence among women with chest pain: The WISE Study." Behavior Modification 2003;27:54-67.
24.30 Chen Q, Reis SE, Kammerer CM, McNamara D, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Bairey Merz CN. "Association between the severity of angiographic coronary disease and paraxonase gene polymorphisms in the National Heart, Lung and Blood Institute sponsored- Women's Ischemia Syndrome Evaluation (WISE) study." Am J Hum Genet 2003;72:13-22.
24.31 Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers WJ, Pohost GM, Kelsey SF, Sopko G "Hypoestrogenemia of hypothalamic origin and coronary artery disease in postmenopausal women: a report from the NHLBI-sponsored WISE study." JACC 2003;41:413-419.
24.32 Chen Q, Reis S, Kammerer C, Craig W, LaPierre S, Zimmer E, McNamara D, Pauly D, Sharaf B, Holubkov R, Merz C, Sopko G, Bontempo F, Kamboh M. "Genetic Variation in the Lectin-Like Oxidized LDL Receptor 1 (LOX1) Gene and the Risk of Coronary Artery Disease." Circulation 2003;107:3146-3151.
24.33 Chen Q, Reis S, Kammerer C, McNamara D, Holubkov R, Sharaf B, Sopko G , Pauly D, Merz C, Kamboh M. "APOE Polymorphism and Angiographic Coronary Artery Disease Severity in the Women's Ischemia Syndrome Evaluation (WISE) Study." Atherosclerosis 2003;169:159-167.
24.34 Rutledge T, Reis S, Olson M, Owens J, Kelsey S, Pepine C, Reichek N, Rogers W, Merz C, Sopko G, Cornell C, Mathews K. "Prospective Mortality Among Women with Chest Pain: The WISE Study." Behavior Modification 2003;27:54-67.
24.35 Marroquin OC, Holubkov R, Edmundowicz D, Rickens CR, Pohost GM, Buchthal S, Pepine CJ, Sopko G, Sembrat RC, Cidis Metzer C, Reis SE. "Heterogenity of microvascular dysfunction in women with chest pain not attributable to coronary disease: implications for clinical practice." Am Heart J 2003;145:628-635.
24.36 Holubkov R, Pepine CJ, Rickens CR, Reichek N, Rogers WJ, Sharaf BL, Sopko G, Bairey Merz CN, Kelsey SF, Olson MB, Smith KM, Reis SE "Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the NHLBI WISE study." Clinical Cardiology 2002;25:553-558.
24.37 Bairey Merz CN, Olson MB, Johnson BD, Bittner V, Hodgson TK, Berga SL, Braunstein GD, Pepine CJ, Reis SE, Sopko G, Kelsey SF. "Cholesterol lowering medication, cholesterol level and reproductive hormones in women: The Women's Ischemia Syndrome Evaluation (WISE)." Am J Med 2002;113:723-727.
24.38 Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, Kerensky R, Bairey Merz CN, Sharaf BL, Sopko G, Rogers WJ, Holubkov R. "Mild renal insufficiency is associated with angiographic coronary artery disease in women." Circulation 2002;105:2826-29.
24.39 Holubkov R, Karas RH, Pepine CJ, Rickens CR, Reichek N, Rogers WJ, Sharaf BL, Sopko G, Bairey Merz CN,Kelsey SF, McGorray SP, Reis SE. "Large brachial artery diameter is associated with angiographic coronary artery disease in women." American Heart Journal 2002;143: 802-7.
24.40 Bairey Merz CN, Johnson BD, Kelsey SF, Reis SE, Lewis JF, Reichek N, Rogers WJ, Pepine CF, Shaw LJ."Diagnostic, prognostic, and cost assessment of coronary artery disease in women." American Journal of Managed Care 2001;7:959-65.
24.41 Reis SE, Holubkov R, Anson J, Smith C, Sharaf BL, Reichek N, Rogers WJ, Merz CNB, Sopko G, Pepine CJ, Kelsey SF. "Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of CAD: Results from the NHLBI WISE Study." AM Heart Journal 2001;141: 735-741.
24.42 Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Merz CNB, Sopko G, Cornell CE, Sharaf B, Matthews KA. "History of anxiety disorders is associated with a decreased likelihood of angiographic CAD in women with chest pain: The WISE Study." JACC March 2001;37(3):780-785.
24.43 Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CNB. "Detailed Angiographic Analysis of Women With Suspected Ischemic Chest Pain (Pilot Phase Data from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory.)" Am J Cardiol 2001;87: 937-941.
24.44 Bairey Merz CN, Olson MB, McGorray S, Pakstis DL, Zell K, Rickens CR, Kelsey SF, Bittner V, Sharaf Bl, Sopko G. "Physical activity and functional capacity measurement in women: A report from the NHLBI-sponsored WISE Study." Journal of Women's Health and Gender-Based Biology 2000;9(7):769-777.
24.45 Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Bairey Merz CN, Sopko G, Reis SE, Cornell CE, Matthews K. "Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: The WISE Study." Psychosomatic Medicine 2000;63: 282-288.
24.46 Olson MB, Kelsey SF, Bittner V, Reis SE, Reichek N, Handberg EM, Bairey Merz CN. "Weight cycling and HDL Cholesterol in women: Evidence of an adverse effect. A report from the NHLBI-sponsored WISE study." JACC 2000;36: 1565-1571.
24.47 Bittner V, Olson MB, Kelsey SF, Rogers WJ, Bairey Merz CN, Armstrong K, Reis SE, Boyette A, Sopko G. "Effect of coronary angiography on use of lipid-lowering agents in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study." Am J of Cardiol 2000;85:1083-1088.
24.48 Buchthal SD, den Hollander JA, Bairey Merz CN, Rogers WJ, Pepine CJ, Reichek N, Reis S, Kelsey SF, Pohost GM, "Abnormal Myocardial Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy in Women With Chest Pain but Normal Coronary Angiograms." NEJM 2000; 342:(12):829-835.
24.49 Bairey Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G. "The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report." JACC May 1999;33(6):1453-1461.
24.50 Lewis JF, Lin L, McGorray S, Pepine CJ, Doyle M, Edmundowicz D, Holubkov R, Pohost G, Reichek N, Rogers W, Sharaf BL, Sopko G, Bairey Merz CN. "Dobutamine stress echocardiography in women with chest pain: Pilot phase data from NHLBI Women's Ischemia Syndrome Evaluation (WISE)." JACC May 1999;33(6):1462-1468.
24.51 Reis SE, Holubkov R, Lee JS, Sharaf BL, Reichek N, Rogers W, Walsh EG, Fuisz AR, Kerensky R, Detre KM, Sopko G, Pepine CJ. "Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE Study)." JACC May 1999;33(6):1469-1475.
|
|
University
of Pittsburgh | Epidemiology Data Center © All Rights Reserved